Below is GEN’s top 15 list of best-selling prescription drugs in 2018. Sales for most treatments grew despite recent concerns over rising prices. Top-selling drugs are […]
Today, some Theranos employees are still trying to move on from a company stained by scandal. These efforts may be complicated by Hollywood’s interest in the […]
Drugmakers looking to buy into gene therapy are finding healthy competition for promising biotechs, highlighting a renewed enthusiasm to develop one-time treatments for genetic diseases. […]
OxyContin maker Purdue Pharma is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging they contributed to the U.S. opioid crisis. […]
Novartis could spend almost $1.6B on a collection of experimental anti-inflammatory drugs from a subsidiary of IFM Therapeutics. IFM has approved the transaction, which they expect […]
The Department of Homeland Security is reportedly considering classifying fentanyl as a weapon of mass destruction. It is weighing whether to classify the opioid drug “when […]
He Jiankui made 2019’s TIME 100 List of most influential people under the category of “Pioneers,” with a feature written by Jennifer Doudna, co-inventor of CRISPR-Cas9 […]
According to an annual patient group opinion report from PatientView, 41% thought the pharma industry’s reputation was “excellent” or “good” in 2018, and 53% of patient […]